2014
DOI: 10.1096/fasebj.28.1_supplement.1152.8
|View full text |Cite
|
Sign up to set email alerts
|

Inhibition of lysyl oxidase activity reverses fibrosis and improves cardiac function (1152.8)

Abstract: The collagen crosslinking enzyme, lysyl oxidase (LOX), is elevated in human dilated cardiomyopathy and heart failure, but it is not known if LOX plays a causative role in disease. However, clinical evidence shows that diuretics with LOX inhibitory properties are more effective at slowing the progression of heart failure. Using the aortocaval fistula (ACF) rat model of volume overload, we assessed the efficacy of LOX inhibition to reverse cardiac fibrosis and dysfunction in rodents with established cardiac dise… Show more

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles